Transporter-mediated drug-drug interactions

被引：0
|
作者：
Shitara, Yoshihisa [1 ]
机构：
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：12 / 13
页数：2
相关论文
共 50 条
  • [31] Transporter-mediated drug-drug interactions involving poly (ADP-ribose) polymerase inhibitors (Review)
    Zhao, Dehua
    Long, Xiaoqing
    Wang, Jisheng
    ONCOLOGY LETTERS, 2023, 25 (04)
  • [32] Identification of Putative Novel Biomarkers of Organic Anion Transporter 1 and 3 for the Prediction of Transporter-Mediated Drug-Drug Interactions
    Thakur, Aarzoo
    Singh, Dilip K.
    Paine, Mary
    Prasad, Bhagwat
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [33] Physiologically Based Pharmacokinetic Modeling of Rosuvastatin and Prediction of Transporter-Mediated Drug-Drug Interactions Involving Gemfibrozil
    Macwan, J. S.
    Lukacova, V.
    Fraczkiewicz, G.
    Bolger, M. B.
    Akhlaghi, F.
    Woltosz, W. S.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S39 - S39
  • [34] Quantitative prediction of transporter-mediated drug-drug interactions using the mechanistic static pharmacokinetic (MSPK) model
    Asano, Satoshi
    Kurosaki, Chie
    Mori, Yuko
    Shigemi, Ryota
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 54
  • [35] Transporter-Mediated Drug-Drug Interactions Involving OATP Substrates: Predictions Based on In Vitro Inhibition Studies
    Yoshida, K.
    Maeda, K.
    Sugiyama, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (06) : 1053 - 1064
  • [36] Comment on the Article “Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions”
    Sibylle Neuhoff
    Geoff T. Tucker
    Pharmaceutical Research, 2013, 30 : 1467 - 1468
  • [37] Progress in the Quantitative Assessment of Transporter-Mediated Drug-Drug Interactions Using Endogenous Substrates in Clinical Studies
    Mochizuki, Tatsuki
    Kusuhara, Hiroyuki
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (09) : 1105 - 1113
  • [38] Metabolism and transporter-mediated drug-drug interactions of the endothelin-A receptor antagonist CI-1034
    Sahi, J
    Sinz, MW
    Campbell, S
    Mireles, R
    Zheng, XX
    Rose, KA
    Raeissi, S
    Hashim, MF
    Ye, YY
    de Morais, SM
    Black, C
    Tugnait, M
    Keller, LH
    CHEMICO-BIOLOGICAL INTERACTIONS, 2006, 159 (02) : 156 - 168
  • [39] Comment on the Article "Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions"
    Neuhoff, Sibylle
    Tucker, Geoff T.
    PHARMACEUTICAL RESEARCH, 2013, 30 (06) : 1467 - 1468
  • [40] Quantitative evaluation of transporter-mediated drug-drug interactions based on a clearance concept and in vitro kinetic parameters
    Yoshida, Kenta
    Maeda, Kazuya
    Kotani, Naoki
    Sugiyama, Yuichi
    DRUG METABOLISM REVIEWS, 2011, 43 : 51 - 51
12345